Immunovant
IMVT
$29.39
Share price
-1.04%
Change (1 day)
63.73%
Change (1 year)
Categories
EPS for Immunovant (IMVT)
EPS in 2023 (TTM): -$1.93
According to Immunovant's latest financial reports the company's current EPS (TTM) is -$1.93. In 2022 the company made an earnings per share (EPS) of -$1.66 a decrease over its 2021 EPS that were of -$1.30.
EPS history for Immunovant from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.93 | 16.27% |
| 2022 | -$1.66 | 27.69% |
| 2021 | -$1.30 | -2.26% |
| 2020 | -$1.33 | 668.98% |
| 2019 | -$0.17 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 12.95% | 🇺🇸 USA |